CD4 and neoplasm: More recently Olkhanud et al. [5] and Tadmor et al. [6] showed that Bregs may facilitate the conversion of CD4+CD25− T cells to CD4+CD25+FoxP3+ Tregs, which in turn attenuate the innate anti-tumor cellular immune response.